Ninety One (UK)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-790,319
Closed -$38.1M 328
2016
Q3
$38.1M Sell
790,319
-8,953
-1% -$453K 0.19% 131
2016
Q2
$44.3M Sell
799,272
-4,893
-0.6% -$270K 0.23% 121
2016
Q1
$42.9M Sell
804,165
-11,850
-1% -$584K 0.23% 114
2015
Q4
$42M Sell
816,015
-18,998
-2% -$944K 0.24% 107
2015
Q3
$37.7M Buy
835,013
+37,408
+5% +$1.77M 0.24% 105
2015
Q2
$36.9M Sell
797,605
-16,943
-2% -$742K 0.21% 115
2015
Q1
$34.9M Buy
+814,548
New +$31M 0.2% 113

Other funds holding PBH

Ninety One (UK)'s PBH Position: Q4 2016 in Review

Ninety One (UK) sold out of Prestige Consumer Healthcare (PBH) in Q4 2016, closing a stake of 790,319 shares — an estimated $38.1M sold.

Ninety One (UK) first reported a position in PBH in Q1 2015 and held it in 7 quarters. The position peaked at $44.3M in Q2 2016. 238 funds tracked by Wall St. Rank hold PBH as of Q4 2016.

  • Ninety One (UK) reported no remaining Prestige Consumer Healthcare position as of Q4 2016 after selling out during the quarter.
  • Ninety One (UK) sold 790,319 Prestige Consumer Healthcare shares in Q4 2016, an estimated $38.1M.
  • Ninety One (UK) first reported a position in Prestige Consumer Healthcare in Q1 2015 and held it in 7 quarters.
  • Ninety One (UK)'s Prestige Consumer Healthcare position peaked at $44.3M in Q2 2016.
  • 238 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2016.

Based on Ninety One (UK)'s 13F filing for Q4 2016, filed 10 Feb 2017.